182 related articles for article (PubMed ID: 25329298)
1. Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants.
Haastrup E; Grau K; Eugen-Olsen J; Thorball C; Kessing LV; Ullum H
PLoS One; 2014; 9(10):e110555. PubMed ID: 25329298
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase plasminogen activator receptor is linearly associated with dietary quality and predicts mortality.
Törnkvist PBS; Haupt TH; Rasmussen LJH; Ladelund S; Toft U; Pisinger C; Eugen-Olsen J
Br J Nutr; 2019 Mar; 121(6):699-708. PubMed ID: 30626457
[TBL] [Abstract][Full Text] [Related]
3. Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism.
Engström G; Zöller B; Svensson PJ; Melander O; Persson M
Thromb Haemost; 2016 Mar; 115(3):657-62. PubMed ID: 26466866
[TBL] [Abstract][Full Text] [Related]
4. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men.
Haugaard SB; Andersen O; Hansen TW; Eugen-Olsen J; Linneberg A; Madsbad S; Olsen MH; Jørgensen T; Borch-Johnsen K; Jeppesen J
Diabet Med; 2012 Apr; 29(4):479-87. PubMed ID: 22050462
[TBL] [Abstract][Full Text] [Related]
5. Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study.
Rasmussen LJ; Ladelund S; Haupt TH; Ellekilde G; Poulsen JH; Iversen K; Eugen-Olsen J; Andersen O
Emerg Med J; 2016 Nov; 33(11):769-775. PubMed ID: 27590986
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
Enocsson H; Wetterö J; Skogh T; Sjöwall C
Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
[TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
[TBL] [Abstract][Full Text] [Related]
8. Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.
Persson M; Engström G; Björkbacka H; Hedblad B
Atherosclerosis; 2012 Feb; 220(2):502-5. PubMed ID: 22119508
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation.
Borné Y; Persson M; Melander O; Smith JG; Engström G
Eur J Heart Fail; 2014 Apr; 16(4):377-83. PubMed ID: 24464777
[TBL] [Abstract][Full Text] [Related]
10. suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.
Meyer J; Alstrup M; Rasmussen LJH; Schultz M; Ladelund S; Haupt TH; Tingleff J; Iversen K; Eugen-Olsen J
Scand J Trauma Resusc Emerg Med; 2018 Feb; 26(1):11. PubMed ID: 29391054
[TBL] [Abstract][Full Text] [Related]
11. Cadmium exposure is associated with soluble urokinase plasminogen activator receptor, a circulating marker of inflammation and future cardiovascular disease.
Fagerberg B; Borné Y; Barregard L; Sallsten G; Forsgard N; Hedblad B; Persson M; Engström G
Environ Res; 2017 Jan; 152():185-191. PubMed ID: 27792942
[TBL] [Abstract][Full Text] [Related]
12. Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol.
Friis Petersen J; Grynnerup AG; Mitchell NH; Løssl K; Sørensen S; Lindhard A; Friis-Hansen L; Pinborg A; Nyboe Andersen A; Løkkegaard E
J Reprod Immunol; 2020 Apr; 138():103103. PubMed ID: 32145561
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of suPAR and hs-CRP on cardiovascular disease.
Diederichsen MZ; Diederichsen SZ; Mickley H; Steffensen FH; Lambrechtsen J; Sand NPR; Christensen KL; Olsen MH; Diederichsen A; Grønhøj MH
Atherosclerosis; 2018 Apr; 271():245-251. PubMed ID: 29402404
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancer.
Rasmussen LJH; Schultz M; Iversen K; Eugen-Olsen J; Helms M; David K; Kjaer A; Lebech AM; Kronborg G
Clin Biochem; 2020 Oct; 84():31-37. PubMed ID: 32504704
[TBL] [Abstract][Full Text] [Related]
15. Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects.
Sørensen MH; Gerke O; Eugen-Olsen J; Munkholm H; Lambrechtsen J; Sand NP; Mickley H; Rasmussen LM; Olsen MH; Diederichsen A
Atherosclerosis; 2014 Nov; 237(1):60-6. PubMed ID: 25222341
[TBL] [Abstract][Full Text] [Related]
16. Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events.
Sehestedt T; Lyngbæk S; Eugen-Olsen J; Jeppesen J; Andersen O; Hansen TW; Linneberg A; Jørgensen T; Haugaard SB; Olsen MH
Atherosclerosis; 2011 May; 216(1):237-43. PubMed ID: 21354571
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia.
Genc A; Kalelioglu T; Karamustafalioglu N; Tasdemir A; Genc ES; Akkus M; Emul M
Psychiatry Res; 2016 Feb; 236():179-181. PubMed ID: 26774189
[TBL] [Abstract][Full Text] [Related]
18. The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study.
Håkansson KEJ; Rasmussen LJH; Godtfredsen NS; Tupper OD; Eugen-Olsen J; Kallemose T; Andersen O; Ulrik CS
Respir Res; 2019 Nov; 20(1):258. PubMed ID: 31730462
[TBL] [Abstract][Full Text] [Related]
19. Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia.
Nielsen J; Røge R; Pristed SG; Viuff AG; Ullum H; Thørner LW; Werge T; Vang T
Schizophr Bull; 2015 May; 41(3):764-71. PubMed ID: 25154621
[TBL] [Abstract][Full Text] [Related]
20. Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.
Ventorp F; Gustafsson A; Träskman-Bendz L; Westrin Å; Ljunggren L
PLoS One; 2015; 10(10):e0140052. PubMed ID: 26451727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
